Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety”

82,636 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 82,636 results

Early research (Phase 1)Ended earlyNCT03956056
What this trial is testing

Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Who this might be right for
Pancreas CancerPancreatic CancerCancer of the Pancreas
Washington University School of Medicine 12
Testing effectiveness (Phase 2)Study completedNCT05197556
What this trial is testing

Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients

Who this might be right for
Obesity
Glaceum 81
Large-scale testing (Phase 3)Study completedNCT01201356
What this trial is testing

Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals 4,125
Testing effectiveness (Phase 2)Study completedNCT00415051
What this trial is testing

Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine

Who this might be right for
Rift Valley Fever
U.S. Army Medical Research and Development Command 20
Post-approval studies (Phase 4)Study completedNCT00290329
What this trial is testing

Safety of Purified Meningococcal Vaccine With Serogroups ACWY, in 3,000 Filipino Subjects Aged > 2 Years

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 249
Testing effectiveness (Phase 2)Study completedNCT05309629
What this trial is testing

Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Qilu Pharmaceutical Co., Ltd. 40
Early research (Phase 1)Study completedNCT01339429
What this trial is testing

Simplified Negative Pressure Wound Therapy

Who this might be right for
Wounds
Brigham and Women's Hospital 41
Post-approval studies (Phase 4)Study completedNCT03346629
What this trial is testing

Outpatient Service for Mid-trimester Termination of Pregnancy

Who this might be right for
Abortion in Second Trimester
Gynuity Health Projects 230
Not applicableStudy completedNCT03009929
What this trial is testing

Validation Study of ClassIntra®

Who this might be right for
Patient SafetyIntraoperative ComplicationsPostoperative Complications+1 more
University Hospital, Basel, Switzerland 2,500
Large-scale testing (Phase 3)Study completedNCT00298831
What this trial is testing

Use of Sugammadex at the End of Case in Routine Anesthesia (MK-8616-023)

Who this might be right for
Anesthesia, General
Merck Sharp & Dohme LLC 224
Testing effectiveness (Phase 2)Study completedNCT01839331
What this trial is testing

An Efficacy and Safety Study of Two Doses of Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee

Who this might be right for
Osteoarthritis of the Knee
Ampio Pharmaceuticals. Inc. 329
Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Not applicableStudy completedNCT02145845
What this trial is testing

Pilot Safety Study of Injectable SIS for Critical Limb Ischemia

Who this might be right for
Critical Limb IschemiaPeripheral Arterial DiseasePeripheral Vascular Disease
Cook Group Incorporated 13
Post-approval studies (Phase 4)Ended earlyNCT01512472
What this trial is testing

Firmagon (Degarelix) Intermittent Therapy

Who this might be right for
Prostate Cancer Recurrent
Canadian Urology Research Consortium 144
Not applicableActive Not RecruitingNCT06710795
What this trial is testing

AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair

Who this might be right for
Ventral Hernia
Medtronic - MITG 35
Post-approval studies (Phase 4)Study completedNCT02866695
What this trial is testing

Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients

Who this might be right for
Actinic Keratosis
University of California, San Francisco 20
Testing effectiveness (Phase 2)Study completedNCT01332695
What this trial is testing

A Pilot Efficacy and Safety Study of ST101 in Essential Tremor

Who this might be right for
Essential Tremor
Sonexa Therapeutics, Inc. 25
Not applicableStudy completedNCT00711139
What this trial is testing

Long-term Safety and Tolerability of AFFITOPE AD01

Who this might be right for
Alzheimer's Disease
Affiris AG 22
Large-scale testing (Phase 3)WithdrawnNCT01124877
What this trial is testing

Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)

Who this might be right for
Bipolar Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Testing effectiveness (Phase 2)Study completedNCT01271777
What this trial is testing

Pilot Study With GFT505 (80mg) in Patients With Insulin Resistance and Abdominal Obesity

Who this might be right for
Insulin ResistanceAbdominal Obesity
Genfit 22
Load More Results